Atrium Therapeutics, Inc. (RNA)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Jun 04, 16:00
12.36
0.00 (0.00%)
After-Hours: 18:09
Atrium Therapeutics Total Assets (Quarterly) : 292.36M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 123.18M |
| Exicure, Inc. | 12.76M |
| Century Therapeutics, Inc. | 326.55M |
| Absci Corp. | 195.59M |
| Celularity, Inc. | 302.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.26M |
| Shareholders Equity (Quarterly) | 234.10M |
| Debt to Equity Ratio | 0.0114 |
| Current Ratio | 13.04 |
| Net Debt Paydown Yield | 0.09% |